{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:21:58Z","timestamp":1794640918933,"version":"4.9.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Institute for Clinical and Experimental Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Radiofrequency ablation of the superior paraseptal ganglionated plexus attenuates vagal modulation of the sinus node (SAN). Ablation from the right-atrium aspect can achieve a sufficient effect. In a randomized study, we investigated the ablation effects of an anatomically prespecified right atrial linear lesion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty patients (age 48\u2009\u00b1\u200913 years, 70% male) with recurrent reflex cardioinhibitory syncope or symptomatic sinus bradycardia underwent cardioneuroablation. A linear lesion consisting of six equidistantly spaced radiofrequency applications (30\u00a0W, 30\u00a0s, 20 mL\/min) fully covering the posteroseptal quadrant of the superior vena cava (SVC) ostium. Patients were randomly assigned (1:1) to mutually opposite directions of lesion creation: posterior-to-septal (Group 1) or septal-to-posterior (Group 2). Sinus rate and SAN responses to extracardiac vagus nerve stimulation (ECVS) were recorded at baseline and after each radiofrequency energy delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      As expected, the complete lesion set in the total cohort significantly increased sinus rate (from 60\u2009\u00b1\u200910 to 80\u2009\u00b1\u200914\u00a0bpm; +35%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and reduced ECVS-induced sinus arrest (from 8.3\u2009\u00b1\u20091.7 to 2.2\u2009\u00b1\u20091.9\u00a0s; -74%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001). The most notable difference between the study groups was observed after performing the initial three lesions. Group 1 showed greater sinus rate acceleration (from 58\u2009\u00b1\u20099 to 80\u2009\u00b1\u200916\u00a0bpm; +39%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) than Group 2 (from 62\u2009\u00b1\u200910 to 72\u2009\u00b1\u20098\u00a0bpm; +18%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05 for between-group difference, and a more pronounced reduction in ECVS-induced sinus arrest (from 7.8\u2009\u00b1\u20091.4 to 1.4\u2009\u00b1\u20090.6\u00a0s; -82%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001) compared to Group 2 (from 8.9\u2009\u00b1\u20091.9 to 5.7\u2009\u00b1\u20093.0\u00a0s; -39%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001 for between-group difference.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Ablation of the posteroseptal quadrant of the SVC ostium significantly modified the vagal input to the sinoatrial node. Lesions targeting the posterior area produced more potent effects than those targeting the septal area.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10840-026-02341-7","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:47:22Z","timestamp":1777528042000},"page":"2711-2718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differential effects of right atrial ablation sites on vagal modulation of the sinus node during cardioneuroablation"],"prefix":"10.1007","volume":"69","author":[{"given":"Peter","family":"\u0160tiavnick\u00fd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0448-5143","authenticated-orcid":false,"given":"Dan","family":"Wichterle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"Helena","family":"Jansov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Peichl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"\u010cih\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Predrag","family":"Stojadinovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Kautzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"4","key":"2341_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/1097-0185(20000801)259:4<353::AID-AR10>3.0.CO;2-R","volume":"259","author":"DH Pauza","year":"2000","unstructured":"Pauza DH, Skripka V, Pauziene N, Stropus R. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec. 2000;259(4):353\u201382. https:\/\/doi.org\/10.1002\/1097-0185(20000801)259:4%3C353::AID-AR10%3E3.0.CO;2-R.","journal-title":"Anat Rec"},{"issue":"2","key":"2341_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/(SICI)1097-0185(199702)247","volume":"247","author":"JA Armour","year":"1997","unstructured":"Armour JA, Murphy DA, Yuan BX, Macdonald S, Hopkins DA. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec. 1997;247(2):289\u201398. https:\/\/doi.org\/10.1002\/(SICI)1097-0185(199702)247. :AID-AR15>3.0.CO;2-L.","journal-title":"Anat Rec"},{"issue":"1","key":"2341_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eupc.2004.10.003","volume":"7","author":"JC Pachon","year":"2005","unstructured":"Pachon JC, Pachon EI, Pachon JC, Lobo TJ, Pachon MZ, Vargas RNA, et al. Cardioneuroablation \u2013 new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation. Europace. 2005;7(1):1\u201313. https:\/\/doi.org\/10.1016\/j.eupc.2004.10.003.","journal-title":"Europace"},{"issue":"5","key":"2341_CR4","doi-asserted-by":"publisher","first-page":"euad033","DOI":"10.1093\/europace\/euad033","volume":"25","author":"M Brignole","year":"2023","unstructured":"Brignole M, Aksu T, Cal\u00f2 L, Debruyne P, Deharo JC, Fanciulli A, et al. Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope. Europace. 2023;25(5):euad033. https:\/\/doi.org\/10.1093\/europace\/euad033.","journal-title":"Europace"},{"issue":"10","key":"2341_CR5","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.hrthm.2019.07.018","volume":"16","author":"F Hu","year":"2019","unstructured":"Hu F, Zheng L, Liang E, Ding L, Wu L, Chen G, Fan X, Yao Y. Right anterior ganglionated plexus: the primary target of cardioneuroablation? Heart Rhythm. 2019;16(10):1545\u201351. https:\/\/doi.org\/10.1016\/j.hrthm.2019.07.018.","journal-title":"Heart Rhythm"},{"key":"2341_CR6","doi-asserted-by":"publisher","unstructured":"Futyma P, Zarebski L, Futyma M, Kulakowski P. Single-shot simplified cardioneuroablation. Europace. 2024;26(Suppl 1). https:\/\/doi.org\/10.1093\/europace\/euae102.166.","DOI":"10.1093\/europace\/euae102.166"},{"issue":"1","key":"2341_CR7","doi-asserted-by":"publisher","first-page":"5926","DOI":"10.1038\/s41598-024-56651-9","volume":"14","author":"Y Han","year":"2024","unstructured":"Han Y, Shao M, Yang H, Sun H, Sang W, Wang L, Wang L, Yang S, Jian Y, Tang B, Li Y. Safety and efficacy of cardioneuroablation for vagal bradycardia in a single arm prospective study. Sci Rep. 2024;14(1):5926. https:\/\/doi.org\/10.1038\/s41598-024-56651-9.","journal-title":"Sci Rep"},{"issue":"3","key":"2341_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10840-020-00840-9","volume":"61","author":"L Calo","year":"2021","unstructured":"Calo L, Rebecchi M, Sette A, Sciarra L, Borrelli A, Scara A, et al. Catheter ablation of right atrial ganglionated plexi to treat cardioinhibitory neurocardiogenic syncope: a long-term follow-up prospective study. J Interv Card Electrophysiol. 2021;61(3):499\u2013510. https:\/\/doi.org\/10.1007\/s10840-020-00840-9.","journal-title":"J Interv Card Electrophysiol"},{"issue":"2","key":"2341_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.hrthm.2024.07.103","volume":"22","author":"A Armani Prata","year":"2025","unstructured":"Armani Prata A, Katsuyama E, Scardini P, Antunes V, Granja J, et al. Cardioneuroablation in patients with vasovagal syncope: an updated systematic review and meta-analysis. Heart Rhythm. 2025;22(2):526\u201335. https:\/\/doi.org\/10.1016\/j.hrthm.2024.07.103.","journal-title":"Heart Rhythm"},{"issue":"10","key":"2341_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.repc.2023.02.012","volume":"42","author":"G Santos Silva","year":"2023","unstructured":"Santos Silva G, Fonseca P, Cardoso F, Almeida J, Ribeiro S, et al. Cardioneuroablation for severe neurocardiogenic syncope. Rev Port Cardiol. 2023;42(10):821\u20139. https:\/\/doi.org\/10.1016\/j.repc.2023.02.012.","journal-title":"Rev Port Cardiol"},{"key":"2341_CR11","doi-asserted-by":"publisher","first-page":"101360","DOI":"10.1016\/j.ijcha.2024.101360","volume":"51","author":"J Joza","year":"2024","unstructured":"Joza J, Bravosi da Rosa LG, Alturki A, Anglesio V, Sanchez-Somonte P, et al. Cardioneuroablation as a strategy to prevent pacemaker implantation in young patients with vasovagal syncope. Int J Cardiol Heart Vasc. 2024;51:101360. https:\/\/doi.org\/10.1016\/j.ijcha.2024.101360.","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"2","key":"2341_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCEP.111.966465","volume":"5","author":"Y Yao","year":"2012","unstructured":"Yao Y, Shi R, Wong T, Zheng L, Chen W, Yang L, et al. Endocardial autonomic denervation of the left atrium to treat vasovagal syncope: an early experience in humans. Circ Arrhythm Electrophysiol. 2012;5(2):279\u201386. https:\/\/doi.org\/10.1161\/CIRCEP.111.966465.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"2341_CR13","doi-asserted-by":"publisher","first-page":"euad170","DOI":"10.1093\/europace\/euad170","volume":"25","author":"P Francia","year":"2023","unstructured":"Francia P, Viveros D, Falasconi G, Soto-Iglesias D, Fern\u00e1ndez-Armenta J, et al. Computed tomography-based identification of ganglionated plexi to guide cardioneuroablation for vasovagal syncope. Europace. 2023;25(6):euad170. https:\/\/doi.org\/10.1093\/europace\/euad170.","journal-title":"Europace"},{"issue":"5","key":"2341_CR14","doi-asserted-by":"publisher","first-page":"euae106","DOI":"10.1093\/europace\/euae106","volume":"26","author":"D Penela","year":"2024","unstructured":"Penela D, Berruezo A, Roten L, Futyma P, Richter S, Falasconi G, et al. Cardioneuroablation for vasovagal syncope: insights on patients\u2019 selection, centre settings, procedural workflow and endpoints \u2013 results from an European Heart Rhythm Association survey. Europace. 2024;26(5):euae106. https:\/\/doi.org\/10.1093\/europace\/euae106.","journal-title":"Europace"},{"issue":"9","key":"2341_CR15","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jacep.2016.12.027","volume":"3","author":"P Debruyne","year":"2017","unstructured":"Debruyne P, Wijns W. Cardio-neuromodulation: the right-sided approach. JACC Clin Electrophysiol. 2017;3(9):1056\u20137. https:\/\/doi.org\/10.1016\/j.jacep.2016.12.027.","journal-title":"JACC Clin Electrophysiol"},{"issue":"8","key":"2341_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.5152\/AnatolJCardiol.2022.217","volume":"26","author":"B Candemir","year":"2022","unstructured":"Candemir B, Baskovski E, Beton O, Shanableh N, Akbulut \u0130M, et al. Procedural characteristics, safety, and follow-up of modified right-sided approach for cardioneuroablation. Anatol J Cardiol. 2022;26(8):629\u201336. https:\/\/doi.org\/10.5152\/AnatolJCardiol.2022.217.","journal-title":"Anatol J Cardiol"},{"issue":"6","key":"2341_CR17","doi-asserted-by":"publisher","first-page":"e009747","DOI":"10.1161\/CIRCEP.120.009747","volume":"14","author":"P Debruyne","year":"2021","unstructured":"Debruyne P, Rossenbacker T, Janssens L, Collienne C, Ector J, Haemers P, et al. Durable physiological changes and decreased syncope burden 12 months after unifocal right-sided ablation under computed tomographic guidance in patients with neurally mediated syncope or functional sinus node dysfunction. Circ Arrhythm Electrophysiol. 2021;14(6):e009747. https:\/\/doi.org\/10.1161\/CIRCEP.120.009747.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"2341_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jacep.2015.06.008","volume":"1","author":"JC Pachon-M","year":"2015","unstructured":"Pachon-M JC, Pachon MEI, Santillana PTG, Lobo TJ, Pachon CTC, et al. Simplified method for vagal effect evaluation in cardiac ablation and electrophysiological procedures. JACC Clin Electrophysiol. 2015;1(5):451\u201360. https:\/\/doi.org\/10.1016\/j.jacep.2015.06.008.","journal-title":"JACC Clin Electrophysiol"},{"key":"2341_CR19","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1016\/j.hrthm.2022.03.268","volume":"19","author":"P \u0160tiavnick\u00fd","year":"2022","unstructured":"\u0160tiavnick\u00fd P, Wichterle D, Jansov\u00e1 H, et al. Heart rate acceleration during cardioneuroablation is a weak predictor of significantly reduced parasympathetic modulation of sinus node (abstract). Heart Rhythm. 2022;19:S260\u20131.","journal-title":"Heart Rhythm"},{"issue":"4","key":"2341_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/jce.16188","volume":"35","author":"JC Pachon-M","year":"2024","unstructured":"Pachon-M JC, Pachon-M EI, Pachon CTC, Santillana-P TG, Lobo TJ, Pachon-M JC, et al. Long-term outcomes of cardioneuroablation with and without extra-cardiac vagal stimulation confirmation in severe cardioinhibitory neurocardiogenic syncope. J Cardiovasc Electrophysiol. 2024;35(4):641\u201350. https:\/\/doi.org\/10.1111\/jce.16188.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"2341_CR21","doi-asserted-by":"publisher","first-page":"euae042","DOI":"10.1093\/europace\/euae042","volume":"26","author":"R Piotrowski","year":"2024","unstructured":"Piotrowski R, Baran J, Sikorska A, Niedzwiedz M, Krynski T, Kulakowski P. Cardioneuroablation: comparison of acute effects of the right vs. left atrial approach in patients with reflex syncope\u2014the ROMAN2 study. Europace. 2024;26(2):euae042. https:\/\/doi.org\/10.1093\/europace\/euae042.","journal-title":"Europace"},{"key":"2341_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10840-024-01968-8","volume":"68","author":"P Francia","year":"2025","unstructured":"Francia P, Viveros D, Gigante C, Falasconi G, Penela D, Soto-Iglesias D, et al. Differential and synergistic effects of right and left atrial ganglionated plexi ablation in patients undergoing cardioneuroablation: results from the ELEGANCE multicenter study. J Interv Card Electrophysiol. 2025;68:195\u2013202. https:\/\/doi.org\/10.1007\/s10840-024-01968-8.","journal-title":"J Interv Card Electrophysiol"},{"issue":"11","key":"2341_CR23","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.hrcr.2022.08.007","volume":"8","author":"T Maher","year":"2022","unstructured":"Maher T, Locke AH, Zinner J, d\u2019Avila A, Shvilkin A. Vasovagal syncope with isolated atrioventricular block following cardioneuroablation demonstrating distinct innervation of the sinus and atrioventricular nodes. Heart Rhythm Case Rep. 2022;8(11):765\u201370. https:\/\/doi.org\/10.1016\/j.hrcr.2022.08.007.","journal-title":"Heart Rhythm Case Rep"},{"issue":"2","key":"2341_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.hrcr.2022.10.012","volume":"9","author":"C Ascione","year":"2023","unstructured":"Ascione C, Benabou L, Hocini M, Ja\u00efs P, Ha\u00efssaguerre M, Duchateau J, Cardioneuroablation. Don\u2019t underestimate the posteromedial left atrial ganglionated plexus. Heart Rhythm Case Rep. 2023;9(2):67\u20139. https:\/\/doi.org\/10.1016\/j.hrcr.2022.10.012.","journal-title":"Heart Rhythm Case Rep"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02341-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02341-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02341-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:51:05Z","timestamp":1794639065000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02341-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2341"],"URL":"https:\/\/doi.org\/10.1007\/s10840-026-02341-7","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The graphical abstract in this paper has been updated to reflect the correct information.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Josef Kautzner reports personal fees from Biosense Webster, Boston Scientific, GE Healthcare, Medtronic, and St. Jude Medical (Abbott) for participation in scientific advisory boards, and speaker honoraria from Biosense Webster, Biotronik, Boston Scientific, Medtronic, ProMed CS, St. Jude Medical (Abbott), and Viatris.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Josef Kautzner reports personal fees from Biosense Webster, Boston Scientific, GE Healthcare, Medtronic, and St. Jude Medical (Abbott) for participation in scientific advisory boards, and speaker honoraria from Biosense Webster, Biotronik, Boston Scientific, Medtronic, ProMed CS, St. Jude Medical (Abbott), and Viatris.Petr Peichl has received speaker honoraria from St. Jude Medical (Abbott) and served as a consultant for Biotronik and Boston Scientific.Dan Wichterle serves as a consultant for Johnson & Johnson MedTech. All other authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}